Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL

Summary

The purpose of this study is to see how well Zevalin works in the treatment of low grade indolent B-cell lymphoma when given to patients who have not had any previous treatment for their lymphoma and who otherwise would be followed on a "watch \& wait" policy.

Timeline

Start

—

Primary completion

—

Completion

—

Outcome

Outcome not reported

Stopped (Business): “Funding will not be provided for the drug”

Drugs

Indications